Table 2

Patient characteristic
Patient characteristics Placebo Cocculine All patients p
Total 217 214 431
Age, years 0.56*
Median (min-max) 52.8 (20–74) 53.3 (30–74) 52.8 (20–74)
Delay from surgery (days)
Median (min-max) 27.50 (4.00–70.0) 27.0 (1.0–72.0) 27.0 (1.0–72.0) 0.90*
ECOG Performance Status n = 197 n = 198 n = 395 0.64†
 0, n (%) 177 (89.8) 175 (88.4) 352 (89.1)
 1, n (%) 20 (10.2) 23 (11.6) 43 (10.9)
Nausea and vomiting susceptibility n = 188 n = 189 n = 377 0.47†
Yes n (%) 63 (33.5) 70 (37.0) 133 (35.3)
pT grade n = 215 n = 211 n = 426 1.00††
 T1 a-b-c, n(%) 119 (55.3) 118 (55.9) 237 (55.6)
 T2, n(%) 87 (40.5) 85 (40.3) 172 (40.4)
 T3, n(%) 7 (3.3) 7 (3.3) 14 (3.3)
 T4, n(%) 2 (0.9) 1 (0.5) 3 (0.7)
pN grade n = 213 n = 213 n = 426 0.84†
 N-, n(%) 85 (39.9) 83 (39.0) 168 (39.4)
 N+, n(%) 128 (60.1) 130 (61.0) 258 (60.6)

*: Mann–Whitney U test; † : Person’s chi-square test; †† : Fischer test.

Pérol et al.

Pérol et al. BMC Cancer 2012 12:603   doi:10.1186/1471-2407-12-603

Open Data